Trial of Andexanet Alfa in ICH Patients Receiving an Oral FXa Inhibitor
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet alfa
versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a
direct oral anticoagulant